ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients

Brain Pathology

Volumn 22, Issue 6, 2012, Pages 788-797

  Alexandra Adam, S ^a   Schnell, Oliver ^a   Pöschl, Julia ^a   Eigenbrod, Sabina ^a   Kretzschmar, Hans A ^a   Tonn, Jörg Christian ^a   Schüller, Ulrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aldh1; astrocytes; development; glioma; survival

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A1; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN S 100; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MATURATION; CONTROLLED STUDY; FETUS; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NERVE CELL DIFFERENTIATION; PRIMARY TUMOR; PROTEIN EXPRESSION; STEM CELL NICHE;

ALDEHYDE DEHYDROGENASE; ASTROCYTES; BRAIN; BRAIN NEOPLASMS; CELL DIFFERENTIATION; DISEASE-FREE SURVIVAL; FETUS; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEUROGENESIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL NICHE; TUMOR MARKERS, BIOLOGICAL;

EID: 84867574748     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2012.00592.x     Document Type: Article

References (27)

1. Campos B, Centner F-S, Bermejo JL, Ali R, Dorsch K, Wan F, et al, (2011) Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas. Am J Pathol 178: 1953-1964.
2. Chang B, Liu GZ, Xue FX, Rosen DG, Xiao LC, Wang XM, et al, (2009) ALDH1 expression correlates with favorable prognosis in ovarian cancers. Mod Pathol 22: 817-823.
3. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al, (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
4. Grasbon-Frodl EM, Kreth FW, Ruiter M, Schnell O, Bise K, Felsberg J, et al, (2007) Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas. Int J Cancer 121: 2458-2464.
5. Hegi ME, Liu LL, Herman JG, Stupp R, Wick W, Weller M, et al, (2008) Correlation of O-6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26: 4189-4199.
6. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, et al, (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69: 3382-3389.
7. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing LX, et al, (2009) Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 7: 330-338.
8. Kahlert C, Bergmann F, Beck J, Welsch T, Mogler C, Herpel E, et al, (2011) Low expression of aldehyde deyhdrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. BMC Cancer 11: 275.
9. Kaplan EL, Meier P, (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481.
10. Kho AT, Zhao Q, Cai Z, Butte AJ, Kim JY, Pomeroy SL, et al, (2004) Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev 18: 629-640.
11. Levi BP, Yilmaz OH, Duester G, Morrison SJ, (2009) Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. Blood 113: 1670-1680.
12. Ligon KL, Huillard E, Mehta S, Kesari S, Liu H, Alberta JA, et al, (2007) Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53: 503-517.
13. Liu QH, Nguyen DH, Dong QH, Shitaku P, Chung K, Liu OY, et al, (2009) Molecular properties of CD133+glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neurooncol 94: 1-19.
14. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, (2007) WHO Classification of Tumours of the Central Nervous System. IARC Press: Lyon.
15. Ma I, Allan AL, (2011) The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 7: 292-306.
16. Marcato P, Dean CA, Giacomantonio CA, Lee PWK, (2011) Aldehyde dehydrogenase Its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 10: 1378-1384.
17. Niederreither K, Fraulob V, Garnier JM, Chambon P, Dollé P, (2002) Differential expression of retinoic acid-synthesizing (RALDH) enzymes during fetal development and organ differentiation in the mouse. Mech Dev 110: 165-171.
18. Pöschl J, Lorenz A, Hartmann W, von Bueren AO, Kool M, Li S, et al, (2011) Expression of BARHL1 in medulloblastoma is associated with prolonged survival in mice and humans. Oncogene 30: 4721-4730.
19. Rasper M, Schäfer A, Piontek G, Teufel J, Brockhoff G, Ringel F, et al, (2011) Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro-Oncol 12: 1024-1033.
20. Rich JN, Eyler CE, (2008) Cancer stem cells in brain tumor biology. In: Control and Regulation of Stem Cells., B Stillman, S Stewart, T Grodzicker, (eds), pp. 411-420. Cold Spring Harbor Laboratory Press: Woodbury.
21. Rodriguez FJ, Giannini C, Asmann YW, Sharma MK, Perry A, Tibbetts KM, et al, (2008) Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase I family member L1 (ALDHIL1) as an underexpressed candidate biomarker in aggressive subtypes. J Neuropathol Exp Neurol 67: 1194-1204.
22. Singh SK, Clarke ID, Hide T, Dirks PB, (2004) Cancer stem cells in nervous system tumors. Oncogene 23: 7267-7273.
23. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al, (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
24. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al, (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
25. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, et al, (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncology 7: 392-401.
26. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al, (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
27. Vogler T, Kriegl L, Horst D, Engel J, Sagebiel S, Schäffauer AJ, et al, (2012) The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors. Exp Mol Pathol 92: 111-117.